Trial Profile
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Depression; Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors GSK
- 04 Nov 2008 Checked against ClinicalTrials.gov record.
- 01 Oct 2005 New trial record.